Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.

Summary

The primary objective of the trial is to assess long-term safety and tolerability of apraglutide in subjects with SBS-IF.

Timeline

Start

2021-07-13

Primary completion

2027-10-30

Completion

2027-10-30

Drugs

Indications